- Home
- THAR vs VEEE Comparison
THAR vs VEEE Comparison
Compare THAR & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- VEEE
- Stock Information
- Founded
- THAR 2017
- VEEE 1994
- Country
- THAR United States
- VEEE United States
- Employees
- THAR N/A
- VEEE N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- VEEE Marine Transportation
- Sector
- THAR Health Care
- VEEE Industrials
- Exchange
- THAR Nasdaq
- VEEE Nasdaq
- Market Cap
- THAR 5.5M
- VEEE 5.1M
- IPO Year
- THAR 2022
- VEEE 2021
- Fundamental
- Price
- THAR $1.46
- VEEE $2.32
- Analyst Decision
- THAR Strong Buy
- VEEE
- Analyst Count
- THAR 1
- VEEE 0
- Target Price
- THAR $17.00
- VEEE N/A
- AVG Volume (30 Days)
- THAR 43.3K
- VEEE 37.1K
- Earning Date
- THAR 08-08-2025
- VEEE 08-13-2025
- Dividend Yield
- THAR N/A
- VEEE N/A
- EPS Growth
- THAR N/A
- VEEE N/A
- EPS
- THAR N/A
- VEEE N/A
- Revenue
- THAR N/A
- VEEE $12,724,465.00
- Revenue This Year
- THAR N/A
- VEEE N/A
- Revenue Next Year
- THAR N/A
- VEEE N/A
- P/E Ratio
- THAR N/A
- VEEE N/A
- Revenue Growth
- THAR N/A
- VEEE N/A
- 52 Week Low
- THAR $0.95
- VEEE $2.05
- 52 Week High
- THAR $6.39
- VEEE $9.30
- Technical
- Relative Strength Index (RSI)
- THAR 39.40
- VEEE 49.57
- Support Level
- THAR $1.60
- VEEE $2.20
- Resistance Level
- THAR $1.75
- VEEE $2.43
- Average True Range (ATR)
- THAR 0.10
- VEEE 0.11
- MACD
- THAR -0.04
- VEEE 0.01
- Stochastic Oscillator
- THAR 1.01
- VEEE 60.71
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.